THE LIVES AFFECTED BY EGFR EXON 20 INSERTION MUTATIONS
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN Study - JTO Clinical and Research Reports
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis | Scientific Reports
Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program - ScienceDirect
Kaplan-Meier survival analysis of patients with NSCLC with or without... | Download Scientific Diagram
Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort - ScienceDirect
Patients with advanced non‑small cell lung cancer with EGFR mutations in addition to complex mutations treated with osimertinib have a poor clinical outcome: A real‑world data analysis
Kaplan–Meier estimates of overall survival according to EGFR status... | Download Scientific Diagram
Kaplan-Meier curves for overall survival of lung adenocarcinoma... | Download Scientific Diagram
Overall survival of EGFR-mutated lung adenocarcinoma patients with or... | Download Scientific Diagram
Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis | European Respiratory Society
Treatment Options for Non-Small Cell Lung Cancer Harboring Uncommon *EGFR* Mutations | Published in healthbook TIMES Oncology Hematology
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM
Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations
Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions | Scientific Reports
Association between EGFR exon 19 or exon 21 mutations and survival rates after first‑line EGFR‑TKI treatment in patients with non‑small cell lung cancer
10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient | European Respiratory Society
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes | SpringerLink
Frontiers | Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New Strategies
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
An exon 21 L858R EGFR mutation is associated with a decreased survival... | Download Scientific Diagram
Cancers | Free Full-Text | A Nationwide Study on the Impact of Routine Testing for EGFR Mutations in Advanced NSCLC Reveals Distinct Survival Patterns Based on EGFR Mutation Subclasses
Effect of gene mutations on the prognosis of lung adenocarcinomas. Blue... | Download Scientific Diagram
Frontiers | Various Subtypes of EGFR Mutations in Patients With NSCLC Define Genetic, Immunologic Diversity and Possess Different Prognostic Biomarkers
